全文获取类型
收费全文 | 168篇 |
免费 | 10篇 |
国内免费 | 3篇 |
专业分类
基础医学 | 7篇 |
口腔科学 | 3篇 |
临床医学 | 8篇 |
内科学 | 63篇 |
神经病学 | 3篇 |
特种医学 | 4篇 |
外科学 | 84篇 |
预防医学 | 2篇 |
眼科学 | 3篇 |
药学 | 3篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 2篇 |
2022年 | 15篇 |
2021年 | 12篇 |
2020年 | 9篇 |
2019年 | 4篇 |
2018年 | 9篇 |
2017年 | 6篇 |
2016年 | 9篇 |
2015年 | 8篇 |
2014年 | 9篇 |
2013年 | 7篇 |
2012年 | 12篇 |
2011年 | 9篇 |
2010年 | 8篇 |
2009年 | 3篇 |
2008年 | 7篇 |
2007年 | 6篇 |
2006年 | 6篇 |
2005年 | 5篇 |
2004年 | 4篇 |
2003年 | 5篇 |
2002年 | 3篇 |
2001年 | 7篇 |
2000年 | 2篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有181条查询结果,搜索用时 15 毫秒
1.
Kazuhiko Tsuruya Atsumi Harada Shinji Kubo Kouji Mitsuiki Kazuhito Takeda 《Clinical and experimental nephrology》1997,1(2):131-135
A 69-year-old man was admitted to our kidney center with endstage renal failure. We started intermittent peritoneal dialysis
immediately because of severe azotemia, hyperkalemia, and metabolic acidosis. Two weeks after admission, he developed uremic
pericarditis with frequent ventricular premature contractions and supraventricular premature contractions. The intermittent
peritoneal dialysis was then replaced by intensive hemodialysis, and oral administration of 300 mg/d of cibenzoline was started.
Four days later, he developed thirst, weakness, and dyspnea due to respiratory muscular paralysis. We initiated respiratory
support with a respirator because analysis of his blood gases revealed marked hypercapnia and hypoxia. He also developed hypoglycemia
and prolonged PQ and QRS intervals on the electrocardiogram, which we believed were due to cibenzoline intoxication; we discontinued
the cibenzoline immediately. All symptoms improved, and he was extubated 5 days later. After 2 months, his pericardial effusion
disappeared. He now continues maintenance hemodialysis as an outpatient. We suspect that the cibenzoline induced the respiratory
muscular paralysis for 2 reasons: 1) the patient experienced the respiratory muscular paralysis, at the same time he also
experienced thirst, weakness, hypoglycemia, and prolonged PQ and QRS intervals on electrocardiogram, and all of these symptoms
improved after the discontinuation of cibenzoline, and 2) his plasma concentration of cibenzoline became remarkably elevated,
to 20 times above the standard therapeutic level. This patient's clinical course indicates that hemodialysis might be superior
to intermittent peritoneal dialysis for treatment of cibenzoline intoxication. 相似文献
2.
Hara Masatoshi Tanaka Shigeru Torisu Kumiko Matsukuma Yuta Tsuchimoto Akihiro Tokumoto Masanori Ooboshi Hiroaki Nakano Toshiaki Tsuruya Kazuhiko Kitazono Takanari 《Clinical and experimental nephrology》2021,25(8):822-834
Clinical and Experimental Nephrology - A growing body of evidence has shown that non-alcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD). Non-invasive fibrosis... 相似文献
3.
4.
Recessive Inheritance of Population‐Specific Intronic LINE‐1 Insertion Causes a Rotor Syndrome Phenotype 下载免费PDF全文
Tatehiro Kagawa Akira Oka Yoshinao Kobayashi Yoichi Hiasa Tsuneo Kitamura Hiroshi Sakugawa Yukihiko Adachi Kazuya Anzai Kota Tsuruya Yoshitaka Arase Shunji Hirose Koichi Shiraishi Takashi Shiina Tadayuki Sato Ting Wang Masayuki Tanaka Hideki Hayashi Noboru Kawabe Peter N. Robinson Tomasz Zemojtel Tetsuya Mine 《Human mutation》2015,36(3):327-332
5.
6.
7.
Shunsuke Yamada Yasuhiro Kawai Shoji Tsuneyoshi Hiroaki Tsujikawa Hokuto Arase Hisako Yoshida Kazuhiko Tsuruya Toshiaki Nakano Takanari Kitazono 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2020,24(1):72-80
Preserving residual kidney function (RKF) is important in the management of patients on peritoneal dialysis. However, few studies have examined the association between serum albumin level and the risk of RKF loss. We prospectively recruited 104 patients who began peritoneal dialysis treatment at our hospital between 2006 and 2016. The primary outcome was complete RKF loss, defined as urine volume < 100 mL/day. Serum albumin level at baseline was the main exposure. During a median observation period of 24 months, 33 patients developed RKF loss. A Cox proportional hazards model showed that hypoalbuminemia was associated with an increased risk of RKF, even after adjustments for potential confounding factors. Multivariable‐adjusted linear regression analysis also showed that hypoalbuminemia was associated with greater rates of decline in 24‐h urine volume and in renal Kt/V urea. Our findings suggest that hypoalbuminemia is associated with an increased risk of RKF loss in patients with peritoneal dialysis. 相似文献
8.
Seishi Aihara Shunsuke Yamada Satoru Shichijo Kento Fukumitsu Mika Kondo Yutaro Hirashima Hideaki Oka Taro Kamimura Atsumi Harada Toshiaki Nakano Kazuhiko Tsuruya Takanari Kitazono 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2020,24(1):34-41
Vascular access intervention therapy (VAIVT) is necessary to maintain vascular access in patients undergoing hemodialysis. VAIVT‐associated vasodilatation is painful. However, few reports have focused on effective pain relief at the time of VAIVT. The present study was performed to determine whether lidocaine‐propitocain cream, a eutectic mixture of local anesthetics (EMLA), effectively reduces VAIVT‐associated pain in patients undergoing hemodialysis. This placebo‐controlled, double‐blind, crossover study was conducted in a single center. Among 210 patients who underwent a total of 437 VAIVT procedures from August 2017 to June 2018, 30 patients were randomly allocated to either the EMLA–placebo arm or placebo–EMLA arm at the time of VAIVT. EMLA application significantly reduced the visual analog scale score compared with placebo (47.0 ± 21.1 vs. 68.6 ± 20.7 mm, respectively; P < 0.05). EMLA is a safe and effective treatment for relief of VAIVT‐associated pain in patients undergoing hemodialysis. 相似文献
9.
Ikeuchi Hidekazu Sugiyama Hitoshi Sato Hiroshi Yokoyama Hitoshi Maruyama Shoichi Mukoyama Masashi Hayashi Hiroki Tsukamoto Tatsuo Fukuda Michio Yamagata Kunihiro Ishikawa Eiji Uchida Keiko Kamijo Yuji Nakagawa Naoki Tsuruya Kazuhiko Nojima Yoshihisa Hiromura Keiju 《Clinical and experimental nephrology》2022,26(9):898-908
Clinical and Experimental Nephrology - The prognosis of lupus nephritis (LN) has improved following the introduction of effective immunosuppressive therapy and progress in supportive care. This... 相似文献
10.
Tanabe Kaori Samejima Kenichi Fukata Fumihiro Kosugi Takaaki Tsushima Hideo Morimoto Katsuhiko Okamoto Keisuke Matsui Masaru Eriguchi Masahiro Maruyama Naoki Akai Yasuhiro Tsuruya Kazuhiko 《Clinical and experimental nephrology》2022,26(4):378-378
Clinical and Experimental Nephrology - In the original publication, the author has found few errors. The corrections are given below. 相似文献